首页 > 最新文献

JAMA surgery最新文献

英文 中文
Bariatric Surgery-A Patient's Perspective. 减肥手术——一个病人的观点。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-02-04 DOI: 10.1001/jamasurg.2025.6379
William B Weeks
{"title":"Bariatric Surgery-A Patient's Perspective.","authors":"William B Weeks","doi":"10.1001/jamasurg.2025.6379","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6379","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bed Capacity and Utilization at Hospitals With Trauma Centers 创伤中心医院的床位容量和使用情况
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-02-04 DOI: 10.1001/jamasurg.2025.6406
Pawan Acharya, Kristan Staudenmayer, Molly P. Jarman, Russell Griffin, Jeffrey D. Kerby, Zain G. Hashmi
Importance As trauma care–related demand continues to rise, the US trauma system’s current utilization and ability to accommodate surges from mass casualty events or disasters remain uncertain. Understanding existing trauma bed occupancy and reserve capacity is essential for national preparedness. Objective To assess the current occupancy and distribution of adult trauma-designated beds across US hospitals and evaluate the system’s ability to absorb a sudden and sustained surge in trauma volume. Design, Setting, and Participants This cross-sectional study analyzed 121 weeks (January 2022–April 2024) of facility-level bed availability and occupancy data from the US Department of Health and Human Services for 2027 hospitals with trauma center designation. Simulation modeling was conducted to evaluate bed capacity under various casualty influx scenarios, assuming a 10% allocation (n = 3610) of the 36 101 adult-trauma designated beds in level I/II centers nationwide. Exposures Various casualty influx scenarios. Main Outcomes and Measures Primary outcomes included mean weekly occupancy rates for adult inpatient and intensive care unit (ICU) beds by trauma center level and region, percentage of centers exceeding 80% occupancy for prolonged durations, and simulated bed deficits under sustained patient influx scenarios. Results Level I and II trauma centers consistently operated at high occupancy, exceeding 80% for inpatient beds and 75% for ICU beds across most regions. Nearly 80% of level I/II centers in the South and West exceeded 80% inpatient occupancy for 75 weeks or longer. In contrast, level III and lower-level centers showed lower occupancy but notable regional variation. Simulation modeling revealed that at sustained influx rates of 1500 to 2000 patients per day, national trauma bed deficits exceeded 20 000 beds within 45 days. Even modest influxes of 241 patients per day saturated all designated trauma beds within 90 days under dynamic length-of-stay assumptions. Conclusions and Relevance The US trauma system, particularly its tertiary centers (level I/II) are operating under sustained high occupancy with limited reserve capacity for patient surges. These findings highlight the urgent need for national trauma capacity planning, regional load-balancing mechanisms, and scalable infrastructure to enhance trauma system resilience.
随着创伤护理相关需求的持续上升,美国创伤系统目前的利用率和适应大规模伤亡事件或灾害激增的能力仍然不确定。了解现有的创伤床位占用率和储备能力对国家准备工作至关重要。目的评估目前美国各医院成人创伤指定床位的占用和分布情况,并评估该系统吸收突然和持续激增的创伤量的能力。设计、环境和参与者本横断面研究分析了121周(2022年1月至2024年4月)美国卫生与公众服务部对2027家指定为创伤中心的医院的设施级床位可用性和占用数据。在全国一级/二级医疗中心36101张成人创伤指定床位中,假设有10%的床位分配(n = 3610),进行了模拟建模,以评估各种伤亡涌入情景下的床位容量。暴露各种伤亡涌入的场景。主要结果和测量方法主要结果包括按创伤中心级别和地区划分的成人住院和重症监护病房(ICU)床位的平均每周入住率,长期入住率超过80%的中心的百分比,以及持续患者涌入情景下的模拟床位不足。结果在大多数地区,一级和二级创伤中心的住院床位占用率超过80%,ICU床位占用率超过75%。南部和西部近80%的1 / 2级中心住院病人入住率超过80%达75周或更长时间。三级及以下中心的占用率较低,但区域差异显著。模拟模型显示,以每天1500至2000名患者的持续流入速度,全国创伤床位缺口在45天内超过2万张。根据动态住院时间假设,即使是每天241名患者的适度流入,也会在90天内使所有指定的创伤病床饱和。结论和意义美国创伤系统,特别是三级中心(一级/二级)在持续高入住率的情况下运行,对患者激增的储备能力有限。这些发现强调了国家创伤能力规划、区域负载平衡机制和可扩展基础设施以增强创伤系统弹性的迫切需要。
{"title":"Bed Capacity and Utilization at Hospitals With Trauma Centers","authors":"Pawan Acharya, Kristan Staudenmayer, Molly P. Jarman, Russell Griffin, Jeffrey D. Kerby, Zain G. Hashmi","doi":"10.1001/jamasurg.2025.6406","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6406","url":null,"abstract":"Importance As trauma care–related demand continues to rise, the US trauma system’s current utilization and ability to accommodate surges from mass casualty events or disasters remain uncertain. Understanding existing trauma bed occupancy and reserve capacity is essential for national preparedness. Objective To assess the current occupancy and distribution of adult trauma-designated beds across US hospitals and evaluate the system’s ability to absorb a sudden and sustained surge in trauma volume. Design, Setting, and Participants This cross-sectional study analyzed 121 weeks (January 2022–April 2024) of facility-level bed availability and occupancy data from the US Department of Health and Human Services for 2027 hospitals with trauma center designation. Simulation modeling was conducted to evaluate bed capacity under various casualty influx scenarios, assuming a 10% allocation (n = 3610) of the 36 101 adult-trauma designated beds in level I/II centers nationwide. Exposures Various casualty influx scenarios. Main Outcomes and Measures Primary outcomes included mean weekly occupancy rates for adult inpatient and intensive care unit (ICU) beds by trauma center level and region, percentage of centers exceeding 80% occupancy for prolonged durations, and simulated bed deficits under sustained patient influx scenarios. Results Level I and II trauma centers consistently operated at high occupancy, exceeding 80% for inpatient beds and 75% for ICU beds across most regions. Nearly 80% of level I/II centers in the South and West exceeded 80% inpatient occupancy for 75 weeks or longer. In contrast, level III and lower-level centers showed lower occupancy but notable regional variation. Simulation modeling revealed that at sustained influx rates of 1500 to 2000 patients per day, national trauma bed deficits exceeded 20 000 beds within 45 days. Even modest influxes of 241 patients per day saturated all designated trauma beds within 90 days under dynamic length-of-stay assumptions. Conclusions and Relevance The US trauma system, particularly its tertiary centers (level I/II) are operating under sustained high occupancy with limited reserve capacity for patient surges. These findings highlight the urgent need for national trauma capacity planning, regional load-balancing mechanisms, and scalable infrastructure to enhance trauma system resilience.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"301 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146116165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To Sleep, Perchance to Heal?: Postoperative Sleep Disruption According to Surgical Risk. 睡一觉,也许就能痊愈?:术后睡眠中断的风险。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-02-04 DOI: 10.1001/jamasurg.2025.6378
Jamie J Coleman, Mitchell J Cohen
{"title":"To Sleep, Perchance to Heal?: Postoperative Sleep Disruption According to Surgical Risk.","authors":"Jamie J Coleman, Mitchell J Cohen","doi":"10.1001/jamasurg.2025.6378","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6378","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative Sleep Dynamics Across Surgical Risk Using Wearable Device Technology 使用可穿戴设备技术跨越手术风险的术后睡眠动态
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-02-04 DOI: 10.1001/jamasurg.2025.6386
Abdulaziz Elemosho, Odysseas P. Chatzipanagiotou, Meher Angez, Andrea Baldo, Areesh Mevawalla, Sebastian O. Ekenze, Qaidar Alizai, Timothy M. Pawlik
Importance Sleep plays a critical role in postoperative recovery, influencing immune function, pain perception, neurocognitive performance, and wound healing. Although surgical interventions are known to disrupt sleep, the extent and trajectory of these disruptions across varying procedural risks remain poorly characterized. Objective To characterize postoperative alterations in sleep stages and determine how these trajectories vary across different surgical procedures. Design, Setting, and Participants This retrospective cohort study used wearable device–derived sleep data linked to electronic health records from US participants in the prospectively maintained All of Us Research Program database. Adults undergoing surgery from January 2012 to December 2024 with 90 days or more of preoperative and 30 days or more of postoperative wearable sleep data were included. Data analyses were performed from July to November 2025. Exposure Surgical intervention stratified by procedural risk levels. Main Outcomes and Measures The primary outcome was sleep metrics, including total sleep and rapid eye movement (REM), deep, light, and wake-stage durations, compared across 9 postoperative epochs and stratified by surgical risk (low, intermediate, or high). Linear mixed-effects models were fitted for each metric with opioid exposure, dose, and patient age as covariates. Association between each sleep metric and postoperative complications was assessed using multivariate logistic regression analysis. Results A total of 634 unique surgical procedures in 512 patients were included in the analytic cohort; median (IQR) patient age at the time of surgery was 59 (46-67) years, and 558 patients (88.0%) were female. High-risk procedures were associated with significant and sustained mean (SD) reductions in REM and deep sleep through postoperative day 7 (deep: Δ, –18.7 [48.6] minutes; <jats:italic toggle="yes">P</jats:italic> &amp;lt; .001; REM: Δ, –12.4 [30.1] minutes; <jats:italic toggle="yes">P</jats:italic> &amp;lt; .001), while total sleep was reduced acutely (Δ, –19.4 [145.3] minutes; <jats:italic toggle="yes">P</jats:italic> = .004). Light sleep decreased transiently; wake-stage duration increased significantly (mean [SD] Δ, +13.9 [31.8] minutes; <jats:italic toggle="yes">P</jats:italic> &amp;lt; .001). Intermediate-risk procedures were associated with milder disruptions, primarily limited to days 0 through 3. In contrast, low-risk procedures were not associated with significant changes in any sleep metric at any postoperative epoch. Opioid exposure was associated with increased light (β, approximately +5.1 minutes; <jats:italic toggle="yes">P</jats:italic> &amp;lt; .001) and wake-stage (+10.2 minutes; <jats:italic toggle="yes">P</jats:italic> &amp;lt; .001) durations but suppressed deep sleep (–5.1 minutes; <jats:italic toggle="yes">P</jats:italic> &amp;lt; .001). Age was similarly linked to greater wake-stage sleep (+0.30 minutes/y) and red
睡眠在术后恢复、影响免疫功能、疼痛感知、神经认知表现和伤口愈合中起着关键作用。虽然已知手术干预会干扰睡眠,但这些干扰的程度和轨迹在不同的手术风险中仍然缺乏特征。目的描述术后睡眠阶段的改变,并确定这些轨迹在不同手术过程中的变化。设计、设置和参与者本回顾性队列研究使用了可穿戴设备衍生的睡眠数据,这些数据与来自美国参与者的电子健康记录相关联,这些数据来自于前瞻性维护的All of US研究计划数据库。纳入了2012年1月至2024年12月接受手术的成年人,术前90天或更长时间,术后30天或更长时间的可穿戴睡眠数据。数据分析时间为2025年7月至11月。暴露:手术干预按手术风险水平分层。主要结局和测量主要结局是睡眠指标,包括总睡眠和快速眼动(REM)、深度、轻度和清醒期持续时间,并根据手术风险(低、中、高)进行分层。以阿片类药物暴露、剂量和患者年龄为协变量,对每个指标拟合线性混合效应模型。采用多变量logistic回归分析评估各睡眠指标与术后并发症之间的关系。结果512例患者的634种独特外科手术被纳入分析队列;手术时患者年龄中位数(IQR)为59(46-67)岁,女性558例(88.0%)。高风险手术与术后第7天REM和深度睡眠显著且持续的平均(SD)减少相关(深度:Δ, -18.7[48.6]分钟;P &lt; 0.001; REM: Δ, -12.4[30.1]分钟;P & lt;。001),而总睡眠时间急剧减少(Δ, -19.4[145.3]分钟;P = 0.004)。轻度睡眠短暂减少;清醒期持续时间显著增加(平均[SD] Δ, +13.9[31.8]分钟;P &lt; .001)。中等风险程序与轻度中断相关,主要限于第0至3天。相比之下,低风险手术与术后任何时期任何睡眠指标的显著变化无关。阿片类药物暴露与光照增加有关(β,约+5.1分钟;P &lt;)。001)和苏醒期(+10.2分钟;P &lt;001)持续时间,但抑制深度睡眠(-5.1分钟;P & lt; .001)。年龄同样与清醒阶段睡眠时间延长(+0.30分钟/年)和恢复性睡眠时间减少(-0.05分钟/年)有关。最后,总睡眠时间每减少10分钟,发生Clavien-Dindo I级和II级并发症的几率就会增加(调整奇数比,1.13 / 10分钟;95% CI, 1.04-1.24; P = 0.006)。根据本队列研究的结果,手术后睡眠结构受到不同程度的破坏,高危手术后出现的损害最大,持续时间最长,快速眼动和深度睡眠受影响最大。
{"title":"Postoperative Sleep Dynamics Across Surgical Risk Using Wearable Device Technology","authors":"Abdulaziz Elemosho, Odysseas P. Chatzipanagiotou, Meher Angez, Andrea Baldo, Areesh Mevawalla, Sebastian O. Ekenze, Qaidar Alizai, Timothy M. Pawlik","doi":"10.1001/jamasurg.2025.6386","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6386","url":null,"abstract":"Importance Sleep plays a critical role in postoperative recovery, influencing immune function, pain perception, neurocognitive performance, and wound healing. Although surgical interventions are known to disrupt sleep, the extent and trajectory of these disruptions across varying procedural risks remain poorly characterized. Objective To characterize postoperative alterations in sleep stages and determine how these trajectories vary across different surgical procedures. Design, Setting, and Participants This retrospective cohort study used wearable device–derived sleep data linked to electronic health records from US participants in the prospectively maintained All of Us Research Program database. Adults undergoing surgery from January 2012 to December 2024 with 90 days or more of preoperative and 30 days or more of postoperative wearable sleep data were included. Data analyses were performed from July to November 2025. Exposure Surgical intervention stratified by procedural risk levels. Main Outcomes and Measures The primary outcome was sleep metrics, including total sleep and rapid eye movement (REM), deep, light, and wake-stage durations, compared across 9 postoperative epochs and stratified by surgical risk (low, intermediate, or high). Linear mixed-effects models were fitted for each metric with opioid exposure, dose, and patient age as covariates. Association between each sleep metric and postoperative complications was assessed using multivariate logistic regression analysis. Results A total of 634 unique surgical procedures in 512 patients were included in the analytic cohort; median (IQR) patient age at the time of surgery was 59 (46-67) years, and 558 patients (88.0%) were female. High-risk procedures were associated with significant and sustained mean (SD) reductions in REM and deep sleep through postoperative day 7 (deep: Δ, –18.7 [48.6] minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001; REM: Δ, –12.4 [30.1] minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001), while total sleep was reduced acutely (Δ, –19.4 [145.3] minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; = .004). Light sleep decreased transiently; wake-stage duration increased significantly (mean [SD] Δ, +13.9 [31.8] minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001). Intermediate-risk procedures were associated with milder disruptions, primarily limited to days 0 through 3. In contrast, low-risk procedures were not associated with significant changes in any sleep metric at any postoperative epoch. Opioid exposure was associated with increased light (β, approximately +5.1 minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001) and wake-stage (+10.2 minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001) durations but suppressed deep sleep (–5.1 minutes; &lt;jats:italic toggle=\"yes\"&gt;P&lt;/jats:italic&gt; &amp;amp;lt; .001). Age was similarly linked to greater wake-stage sleep (+0.30 minutes/y) and red","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"9 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146116135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distance of Mass School Shootings From Trauma Centers. 大规模校园枪击案与创伤中心的距离
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-02-04 DOI: 10.1001/jamasurg.2025.6382
Bao Ngoc Vi Do, Jayson Willard Myers, Paras Singh Minhas
{"title":"Distance of Mass School Shootings From Trauma Centers.","authors":"Bao Ngoc Vi Do, Jayson Willard Myers, Paras Singh Minhas","doi":"10.1001/jamasurg.2025.6382","DOIUrl":"10.1001/jamasurg.2025.6382","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12874072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National System Preparation in Dire Need-Call for Action. 迫切需要的国家系统准备——行动呼吁。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-02-04 DOI: 10.1001/jamasurg.2025.6415
Kelly A Boyle, David Milia, Marc de Moya
{"title":"National System Preparation in Dire Need-Call for Action.","authors":"Kelly A Boyle, David Milia, Marc de Moya","doi":"10.1001/jamasurg.2025.6415","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6415","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146119007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Figure. 图中出现错误。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-28 DOI: 10.1001/jamasurg.2025.6505
{"title":"Error in Figure.","authors":"","doi":"10.1001/jamasurg.2025.6505","DOIUrl":"10.1001/jamasurg.2025.6505","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12853281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146063545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wearable Antiemetics. 耐磨止吐药。
IF 14.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-28 DOI: 10.1001/jamasurg.2025.6403
Oliver Aalami
{"title":"Wearable Antiemetics.","authors":"Oliver Aalami","doi":"10.1001/jamasurg.2025.6403","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6403","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":" ","pages":""},"PeriodicalIF":14.9,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146063574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supervised Multimodal Prehabilitation and Clinical Outcomes in Older Patients With Frailty and Gastric Cancer: The GISSG+2201 Randomized Clinical Trial. GISSG+2201随机临床试验:老年虚弱和胃癌患者的监督多模式预康复和临床结局
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-28 DOI: 10.1001/jamasurg.2025.6256
Yuqi Sun,Yulong Tian,Shougen Cao,Leping Li,Wenbin Yu,Yinlu Ding,Xixun Wang,Ying Kong,Xinjian Wang,Hao Wang,Xizeng Hui,Jianjun Qu,Hongbo Wang,Quanhong Duan,Daogui Yang,Huanhu Zhang,Shaofei Zhou,Xiaodong Liu,Zequn Li,Qi Liu,Yanbing Zhou
ImportanceFrailty is associated with functional decline and increased postoperative morbidity. Prehabilitation may complement Enhanced Recovery After Surgery (ERAS) care to improve patient outcomes.ObjectiveTo evaluate the effect of a multimodal prehabilitation program on functional capacity and clinical outcomes in older patients with frailty undergoing radical gastrectomy.Design, Setting, and ParticipantsThis randomized clinical trial was conducted at 15 centers in China. Participants aged 65 to 85 years with frailty (Geriatric 8 screening tool score ≤14) scheduled for elective gastrectomy or neoadjuvant chemotherapy prior to elective gastrectomy were randomized 1:1 to ERAS care either with or without prehabilitation. Recruitment for the study began in September 2022 and was completed in April 2024; data analysis was completed from September 2024 to April 2025.InterventionsThe prehabilitation group (PG) underwent multimodal prehabilitation for at least 2 weeks in combination with ERAS care, while the standard ERAS group (SG) followed a well-defined ERAS pathway.Main Outcomes and MeasuresThe primary outcome was the proportion of patients with postoperative complications within 30 days after surgery. Secondary outcomes included functional capacity, surgical resilience, and other short-term postoperative outcomes.ResultsA total of 368 participants were randomized to either the PG or SG group. In the modified intention-to-treat population of 347 participants (PG: n = 169; SG: n = 178), overall compliance with prehabilitation was 93.75%; median (IQR) participant age was 70 (68-73) years, and 95 participants (27.4%) were female. The rate of complications was lower in PG compared to SG (17.2% vs 28.7%; P = .01). In particular, significant benefits were observed in minor complications (PG: 18 of 169 patients [10.7%]; SG: 36 of 178 patients [20.2%]; P = .01) and medical complications (PG: 14 of 169 patients [8.3%]; SG: 30 of 178 patients [16.9%]; P = .02). The PG showed increased functional capacity before surgery compared to baseline (mean [SD] 6-minute walk test change, +24 [12.5] m; P < .001). Four weeks after surgery, the mean walking distance of the PG remained above baseline levels. Moreover, secondary parameters, such as chronic low-grade inflammation, preoperative physical quality of life, length of intensive care unit stay, mechanical ventilation time, and length of hospital stay, generally favored prehabilitation compared with standard ERAS care.Conclusions and RelevancePer the results of this randomized clinical trial, a multimodal prehabilitation program may enhance physiological reserve, reduce morbidity, and promote surgical resilience in older patients with frailty undergoing radical gastrectomy.Trial RegistrationClinicalTrials.gov Identifier: NCT05352802.
虚弱与功能下降和术后发病率增加有关。预康复可以补充术后增强恢复(ERAS)护理,以改善患者的预后。目的评价多模式康复方案对行根治性胃切除术的老年虚弱患者功能能力和临床预后的影响。设计、环境和参与者本随机临床试验在中国的15个中心进行。年龄在65 ~ 85岁之间,体弱者(Geriatric 8筛查工具评分≤14)计划择期胃切除术或择期胃切除术前新辅助化疗的参与者按1:1的比例随机分配到有或没有预适应的ERAS治疗组。该研究的招募于2022年9月开始,并于2024年4月完成;数据分析于2024年9月至2025年4月完成。干预措施:预康复组(PG)在ERAS护理的同时进行至少2周的多模式预康复,而标准ERAS组(SG)则遵循明确的ERAS途径。主要结局和措施主要结局是术后30天内出现术后并发症的患者比例。次要结局包括功能能力、手术恢复力和其他短期术后结局。结果共有368名参与者被随机分为PG组和SG组。在347名受试者(PG: n = 169; SG: n = 178)的改良意向治疗人群中,总体康复依从性为93.75%;参与者年龄中位数(IQR)为70(68-73)岁,95名参与者(27.4%)为女性。PG组并发症发生率低于SG组(17.2% vs 28.7%; P = 0.01)。特别是,在轻微并发症方面观察到显著的益处(PG: 169例患者中有18例[10.7%];SG: 178例患者中有36例[20.2%];P =。01)和医学并发症(169例患者中PG: 14例[8.3%];178例患者中SG: 30例[16.9%];P = 0.02)。与基线相比,PG术前功能能力增加(平均[SD] 6分钟步行测试变化,+24 [12.5]m; P < .001)。术后4周,PG的平均步行距离仍高于基线水平。此外,次要参数,如慢性低度炎症、术前身体生活质量、重症监护病房住院时间、机械通气时间和住院时间,与标准ERAS护理相比,普遍倾向于康复治疗。结论和相关性根据这项随机临床试验的结果,多模式的康复计划可以增强接受根治性胃切除术的老年虚弱患者的生理储备,降低发病率,并提高手术恢复能力。临床试验注册号:NCT05352802。
{"title":"Supervised Multimodal Prehabilitation and Clinical Outcomes in Older Patients With Frailty and Gastric Cancer: The GISSG+2201 Randomized Clinical Trial.","authors":"Yuqi Sun,Yulong Tian,Shougen Cao,Leping Li,Wenbin Yu,Yinlu Ding,Xixun Wang,Ying Kong,Xinjian Wang,Hao Wang,Xizeng Hui,Jianjun Qu,Hongbo Wang,Quanhong Duan,Daogui Yang,Huanhu Zhang,Shaofei Zhou,Xiaodong Liu,Zequn Li,Qi Liu,Yanbing Zhou","doi":"10.1001/jamasurg.2025.6256","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6256","url":null,"abstract":"ImportanceFrailty is associated with functional decline and increased postoperative morbidity. Prehabilitation may complement Enhanced Recovery After Surgery (ERAS) care to improve patient outcomes.ObjectiveTo evaluate the effect of a multimodal prehabilitation program on functional capacity and clinical outcomes in older patients with frailty undergoing radical gastrectomy.Design, Setting, and ParticipantsThis randomized clinical trial was conducted at 15 centers in China. Participants aged 65 to 85 years with frailty (Geriatric 8 screening tool score ≤14) scheduled for elective gastrectomy or neoadjuvant chemotherapy prior to elective gastrectomy were randomized 1:1 to ERAS care either with or without prehabilitation. Recruitment for the study began in September 2022 and was completed in April 2024; data analysis was completed from September 2024 to April 2025.InterventionsThe prehabilitation group (PG) underwent multimodal prehabilitation for at least 2 weeks in combination with ERAS care, while the standard ERAS group (SG) followed a well-defined ERAS pathway.Main Outcomes and MeasuresThe primary outcome was the proportion of patients with postoperative complications within 30 days after surgery. Secondary outcomes included functional capacity, surgical resilience, and other short-term postoperative outcomes.ResultsA total of 368 participants were randomized to either the PG or SG group. In the modified intention-to-treat population of 347 participants (PG: n = 169; SG: n = 178), overall compliance with prehabilitation was 93.75%; median (IQR) participant age was 70 (68-73) years, and 95 participants (27.4%) were female. The rate of complications was lower in PG compared to SG (17.2% vs 28.7%; P = .01). In particular, significant benefits were observed in minor complications (PG: 18 of 169 patients [10.7%]; SG: 36 of 178 patients [20.2%]; P = .01) and medical complications (PG: 14 of 169 patients [8.3%]; SG: 30 of 178 patients [16.9%]; P = .02). The PG showed increased functional capacity before surgery compared to baseline (mean [SD] 6-minute walk test change, +24 [12.5] m; P < .001). Four weeks after surgery, the mean walking distance of the PG remained above baseline levels. Moreover, secondary parameters, such as chronic low-grade inflammation, preoperative physical quality of life, length of intensive care unit stay, mechanical ventilation time, and length of hospital stay, generally favored prehabilitation compared with standard ERAS care.Conclusions and RelevancePer the results of this randomized clinical trial, a multimodal prehabilitation program may enhance physiological reserve, reduce morbidity, and promote surgical resilience in older patients with frailty undergoing radical gastrectomy.Trial RegistrationClinicalTrials.gov Identifier: NCT05352802.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"87 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146056868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanding the Prehabilitation Team Beyond the Clinic. 将康复团队拓展到诊所之外。
IF 16.9 1区 医学 Q1 SURGERY Pub Date : 2026-01-28 DOI: 10.1001/jamasurg.2025.6255
Liane S Feldman,Franco Carli,Janius Tsang
{"title":"Expanding the Prehabilitation Team Beyond the Clinic.","authors":"Liane S Feldman,Franco Carli,Janius Tsang","doi":"10.1001/jamasurg.2025.6255","DOIUrl":"https://doi.org/10.1001/jamasurg.2025.6255","url":null,"abstract":"","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"12 1","pages":""},"PeriodicalIF":16.9,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146056860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAMA surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1